We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-0.6%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$44.1B
AUM Growth
-$1.93B
Cap. Flow
-$863M
Cap. Flow %
-1.96%
Top 10 Hldgs %
24.82%
Holding
984
New
120
Increased
284
Reduced
350
Closed
125

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$192M
2
ATVI
Activision Blizzard
ATVI
+$151M
3
DOV icon
Dover
DOV
+$127M
4
HON icon
Honeywell
HON
+$123M
5
CVX icon
Chevron
CVX
+$107M

Sector Composition

Rank Sector Weight
1 Technology 25.68%
2 Healthcare 17.44%
3 Financials 11.47%
4 Consumer Discretionary 9.72%
5 Industrials 9.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNTB
776
Connect Biopharma Holdings
CNTB
$138M
$532K ﹤0.01%
650,000
HHRS
777
DELISTED
Hammerhead Energy Inc. Class A Common Stock
HHRS
$530K ﹤0.01%
+44,400
New +$448K
BOLT icon
778
Bolt Biotherapeutics
BOLT
$7.44M
$520K ﹤0.01%
25,000
BTAI icon
779
BioXcel Therapeutics
BTAI
$25.6M
$506K ﹤0.01%
12,500
-109,531
-90% -$11.1M
TERN
780
DELISTED
Terns Pharmaceuticals
TERN
$503K ﹤0.01%
100,000
-50,000
-33% -$317K
OKUR
781
OnKure Therapeutics
OKUR
$168M
$495K ﹤0.01%
+6,500
New +$442K
KRRO icon
782
Korro Bio
KRRO
$175M
$444K ﹤0.01%
+24,000
New +$602K
KITT icon
783
Nauticus Robotics
KITT
$7.32M
$428K ﹤0.01%
93
+49
+111% +$253K
CMRX
784
DELISTED
Chimerix, Inc.
CMRX
$384K ﹤0.01%
400,000
LNZA icon
785
LanzaTech
LNZA
$68M
$347K ﹤0.01%
743
AMC icon
786
AMC Entertainment Holdings
AMC
$2.29B
$337K ﹤0.01%
+42,150
New +$1.25M
SNA icon
787
Snap-on
SNA
$21.5B
$325K ﹤0.01%
+1,274
New +$344K
ERII icon
788
Energy Recovery
ERII
$450M
$306K ﹤0.01%
+14,407
New +$385K
IVCBW
789
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$298K ﹤0.01%
1,000,000
BIO icon
790
Bio-Rad Laboratories Class A
BIO
$9.16B
$290K ﹤0.01%
810
-20,500
-96% -$7.91M
NINE
791
DELISTED
Nine Energy Service
NINE
$288K ﹤0.01%
+70,000
New +$315K
CANO
792
DELISTED
Cano Health, Inc.
CANO
$254K ﹤0.01%
10,000
FET icon
793
Forum Energy Technologies
FET
$846M
$240K ﹤0.01%
10,000
NEO icon
794
NeoGenomics
NEO
$2B
$229K ﹤0.01%
18,620
-181,380
-91% -$2.7M
ITOS
795
DELISTED
iTeos Therapeutics
ITOS
$219K ﹤0.01%
+20,000
New +$256K
AL
796
DELISTED
Air Lease Corp
AL
$214K ﹤0.01%
+5,442
New +$224K
LNZAW icon
797
LanzaTech Global Warrant
LNZAW
$3.65M
$209K ﹤0.01%
342,500
BRLSW icon
798
Borealis Foods Inc Warrant
BRLSW
$949K
$195K ﹤0.01%
1,116,667
-183,333
-14% -$23.3K
NKTX icon
799
Nkarta
NKTX
$164M
$194K ﹤0.01%
139,300
NEXI
800
DELISTED
NexImmune, Inc. Common Stock
NEXI
$168K ﹤0.01%
32,055

Similar funds

Adage Capital Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Adage Capital Partners held 984 positions worth $44.1B, down 4.2% from $46B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Adage Capital Partners's Q3 2023 filing shows 120 new, 284 increased, 350 reduced and 125 closed positions. Its largest new stake was Blackstone: 705,700 shares worth $75.6M. The largest sale was Boeing, an estimated $282M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2023 buy was Blackstone: 705,700 shares worth $75.6M.
  • Adage Capital Partners added most to Emerson Electric in Q3 2023, an estimated $192M increase.
  • Adage Capital Partners's biggest Q3 2023 reduction was Boeing, cutting an estimated $282M.
  • Adage Capital Partners fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $180M.
  • Adage Capital Partners's ten largest holdings make up 25% of its $44.1B portfolio in Q3 2023.
  • Adage Capital Partners opened 120 new positions and closed 125 in Q3 2023.
  • Adage Capital Partners's portfolio value fell 4.2% quarter-over-quarter to $44.1B.

Based on Adage Capital Partners's 13F filing for Q3 2023, filed 14 Nov 2023.